Thomas Shaw‐Stiffel

962 total citations
21 papers, 633 citations indexed

About

Thomas Shaw‐Stiffel is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Thomas Shaw‐Stiffel has authored 21 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Thomas Shaw‐Stiffel's work include Liver Disease and Transplantation (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Thomas Shaw‐Stiffel is often cited by papers focused on Liver Disease and Transplantation (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Thomas Shaw‐Stiffel collaborates with scholars based in United States, Canada and Germany. Thomas Shaw‐Stiffel's co-authors include Amadeo Marcos, Larry H. Bernstein, Jared Klarquist, Hanne Thiede, Meighan Krows, Chia C. Wang, Elizabeth M. Krantz, Edward P. Scott, Anna Wald and Hugo R. Rosen and has published in prestigious journals such as Gastroenterology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Thomas Shaw‐Stiffel

19 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Shaw‐Stiffel United States 11 383 278 255 105 67 21 633
H Tenckhoff Germany 15 271 0.7× 333 1.2× 202 0.8× 41 0.4× 29 0.4× 30 1.1k
N. Terreni Italy 11 600 1.6× 519 1.9× 375 1.5× 135 1.3× 67 1.0× 19 938
Caroline Jézequel France 14 275 0.7× 199 0.7× 221 0.9× 41 0.4× 59 0.9× 32 532
G Marenco Italy 9 356 0.9× 333 1.2× 299 1.2× 24 0.2× 17 0.3× 21 663
Nadia Ovchinsky United States 11 186 0.5× 228 0.8× 162 0.6× 29 0.3× 34 0.5× 33 456
Rajeev Khanna India 16 674 1.8× 494 1.8× 452 1.8× 28 0.3× 45 0.7× 96 1.0k
Kenneth D. Rothstein United States 15 621 1.6× 370 1.3× 382 1.5× 27 0.3× 13 0.2× 40 860
N. Declerck France 14 266 0.7× 135 0.5× 370 1.5× 63 0.6× 20 0.3× 30 641
S Emre United States 11 277 0.7× 169 0.6× 349 1.4× 26 0.2× 16 0.2× 26 667
J. M. Langrehr Germany 18 286 0.7× 139 0.5× 433 1.7× 18 0.2× 62 0.9× 53 691

Countries citing papers authored by Thomas Shaw‐Stiffel

Since Specialization
Citations

This map shows the geographic impact of Thomas Shaw‐Stiffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Shaw‐Stiffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Shaw‐Stiffel more than expected).

Fields of papers citing papers by Thomas Shaw‐Stiffel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Shaw‐Stiffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Shaw‐Stiffel. The network helps show where Thomas Shaw‐Stiffel may publish in the future.

Co-authorship network of co-authors of Thomas Shaw‐Stiffel

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Shaw‐Stiffel. A scholar is included among the top collaborators of Thomas Shaw‐Stiffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Shaw‐Stiffel. Thomas Shaw‐Stiffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly, Erin, Paul D. James, Sanjay K. Murthy, et al.. (2019). Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents. Clinical Gastroenterology and Hepatology. 17(11). 2339–2346.e1. 24 indexed citations
2.
Reinglas, Jason, et al.. (2016). The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX©Catheter. Canadian Journal of Gastroenterology and Hepatology. 2016. 1–7. 26 indexed citations
3.
4.
Asmis, Timothy R., Fady Balaa, Linda Scully, et al.. (2010). Diagnosis and Management of Hepatocellular Carcinoma: Results of a Consensus Meeting of The Ottawa Hospital Cancer Centre. Current Oncology. 17(2). 6–12. 8 indexed citations
5.
Kroeker, Karen I., Vincent G. Bain, Thomas Shaw‐Stiffel, Tse–Ling Fong, & Eric M. Yoshida. (2008). Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007. Liver International. 28(9). 1250–1255. 21 indexed citations
6.
Sass, David A., Kenneth Clark, Dana M. Grzybicki, Mordechai Rabinovitz, & Thomas Shaw‐Stiffel. (2007). Diffuse Desmoplastic Metastatic Breast Cancer Simulating Cirrhosis with Severe Portal Hypertension: A Case of “Pseudocirrhosis”. Digestive Diseases and Sciences. 52(3). 749–752. 42 indexed citations
7.
Wang, Chia C., Elizabeth M. Krantz, Jared Klarquist, et al.. (2007). Acute Hepatitis C in a Contemporary US Cohort: Modes of Acquisition and Factors Influencing Viral Clearance. The Journal of Infectious Diseases. 196(10). 1474–1482. 137 indexed citations
8.
Bhat, Yasser M., et al.. (2006). Acute Liver Failure as an Initial Manifestation of an Infiltrative Hematolymphoid Malignancy. Digestive Diseases and Sciences. 51(1). 63–67. 6 indexed citations
9.
Demetris, Anthony J., Dympna Kelly, Bijan Eghtesad, et al.. (2006). Pathophysiologic Observations and Histopathologic Recognition of the Portal Hyperperfusion or Small-for-Size Syndrome. The American Journal of Surgical Pathology. 30(8). 986–993. 147 indexed citations
10.
Bogin, Vladimir, Amadeo Marcos, & Thomas Shaw‐Stiffel. (2005). Budd-Chiari syndrome. European Journal of Gastroenterology & Hepatology. 17(1). 33–35. 26 indexed citations
11.
Shaw‐Stiffel, Thomas. (2004). Focus on hepatitis. Weight-based versus fixed-dose peginterferons.. PubMed. 10(5). 178–80. 1 indexed citations
12.
Shaw‐Stiffel, Thomas, et al.. (2002). Hepatic disease in injection drug users. Infectious Disease Clinics of North America. 16(3). 667–679. 7 indexed citations
13.
Burton, James R., Charlotte Ryan, & Thomas Shaw‐Stiffel. (2002). Liver Transplantation in Mushroom Poisoning. Journal of Clinical Gastroenterology. 35(3). 276–280. 10 indexed citations
14.
Bernstein, Larry H., et al.. (1996). An informational approach to likelihood of malnutrition. Nutrition. 12(11-12). 772–776. 1 indexed citations
15.
Shaw‐Stiffel, Thomas, et al.. (1995). Update on the Use of Metabolic Probes to Quantify Liver Function: Caffeine versus Lidocaine. Digestive Diseases. 13(4). 239–250. 4 indexed citations
16.
Shaw‐Stiffel, Thomas, et al.. (1995). The gastrointestinal manifestations of Sjögren's syndrome.. PubMed. 90(1). 9–14. 59 indexed citations
17.
Shaw‐Stiffel, Thomas, et al.. (1994). Pharmacokinetic and pharmacodynamic interactions during multiple-dose administration of nisoldipine and propranolol. Clinical Pharmacology & Therapeutics. 55(6). 661–669. 7 indexed citations
18.
Shaw‐Stiffel, Thomas, et al.. (1993). Effect of nutrition status and other factors on length of hospital stay after major gastrointestinal surgery.. PubMed. 9(2). 140–5. 58 indexed citations
19.
Bernstein, Larry H., et al.. (1993). Financial Implications of Malnutrition. Clinics in Laboratory Medicine. 13(2). 491–507. 34 indexed citations
20.
Shaw‐Stiffel, Thomas, Peter J. Campbell, Michael J. Sole, et al.. (1988). Renal prostaglandin E2 and other vasoactive modulators in refractory hepatic ascites: Response to peritoneovenous shunting. Gastroenterology. 95(5). 1332–1338. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Tenckhoff Breakdown of academic impact, for papers by N. Terreni Breakdown of academic impact, for papers by Caroline Jézequel Breakdown of academic impact, for papers by G Marenco Breakdown of academic impact, for papers by Nadia Ovchinsky Breakdown of academic impact, for papers by Rajeev Khanna Breakdown of academic impact, for papers by Kenneth D. Rothstein Breakdown of academic impact, for papers by N. Declerck Breakdown of academic impact, for papers by S Emre Breakdown of academic impact, for papers by J. M. Langrehr
Rankless by CCL
2026